Keyphrases
Antitumor Activity
100%
T Cells
100%
Tumor Infiltration
100%
Adoptive Immunotherapy
100%
BRAF Inhibition
100%
BRAF Inhibitor (BRAFi)
75%
PLX4720
75%
Tumor
50%
Human Melanoma
50%
Adoptive Cell Therapy
50%
Melanoma Patients
50%
Gp100
50%
Pmel
50%
Melanoma Tumor Cells
50%
Protein Array
25%
Immunohistochemistry
25%
Tumor Biopsy
25%
Melanoma
25%
Clinical Response
25%
Tumor Cell Lines
25%
Immune Response
25%
Patient Samples
25%
Patient Tumor
25%
C-Myc
25%
T Cell Infiltration
25%
Cell-based
25%
Potential Clinical Applications
25%
Luciferase
25%
Xenograft Model
25%
Melanoma Treatment
25%
Inhibitor Treatment
25%
Cell Manufacturing
25%
T Cell Migration
25%
VEGF Expression
25%
BRAF mutant
25%
VEGF Promoter
25%
In Vivo murine Model
25%
Melanocyte Differentiation Antigens
25%
Antigen-independent
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Antitumor Activity
100%
Immunotherapy
100%
Vasculotropin
71%
Melanoma
71%
N [3 (5 Chloro 1h pyrrolo[2,3 B]pyridine 3 Carbonyl) 2,4 Difluorophenyl]propanesulfonamide
42%
Glycoprotein Gp 100
28%
Luciferase
14%
Enzyme-Linked Immunosorbent Assay
14%
Differentiation Antigen
14%
Immunology and Microbiology
T Cell
100%
Antineoplastic Activity
100%
Adoptive Immunotherapy
100%
Vasculotropin
55%
Cell Migration
11%
Promoter Region
11%
Xenograft
11%
Tumor Cell Line
11%
Tumor Cell
11%
Immune Response
11%
Downregulation
11%
Immunotherapy
11%
ELISA
11%
Oncogene C Myc
11%
Cell Infiltration
11%
Differentiation Antigen
11%
Melanocyte
11%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
100%
T Cell
100%
Vascular Endothelial Growth Factor
55%
Protein Microarray
11%
Luciferase
11%
Cell Migration
11%
Promoter Region
11%
Downregulation
11%
Immune Response
11%
Oncogene C Myc
11%
Melanocyte
11%
Cell Infiltration
11%